(Date:11/25/2009)... Pharmasset, Inc. (Nasdaq... committed to discovering, developing and commerci...orted financial results for the fiscal year ended ...et held $58.4 million in cash, cash equivalents an...and 2009 Highlights ,, RG7128 ,, Phase ...
(Date:11/25/2009)...ov. 25 For many of the m...the 27 million living with untreated hearing loss...diologist Cindy Beyer. ,, Dr. Beyer, senior vic...ca,s largest hearing care and hearing aids compa...ess, frustration, and social isolation, "which can...
(Date:11/25/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, United States Dental Devices Market A...eportlinker.com/p0158733/United-States-Dental-Devi..., United States Dental Devices Market Analysis a...port is an essential source for in-depth informati...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Program Curbs Teen Substance Abuse Delinquency 56342 1Program Curbs Teen Substance Abuse Delinquency 56342 2Even Mild Infections Hasten Decline With Alzheimers 56340 1Even Mild Infections Hasten Decline With Alzheimers 56340 2Even Mild Infections Hasten Decline With Alzheimers 56340 3Researchers find first evidence of virus in malignant prostate cells 9818 1Researchers find first evidence of virus in malignant prostate cells 9818 2Researchers find first evidence of virus in malignant prostate cells 9818 3..., Pa., Oct. 3 ViroPharma Incorporated,(Nasdaq: V...ent and chief,executive officer of ViroPharma, wil...t 10:30 A.M. ET on Monday, October 8, 2007. The co... York. ViroPharma,s presentation will be webcast ...com and available through October 22, 2007. Abou...
... Subcutaneous Doses of Ustekinumab Resulted in Lon...n Quality of Life Measures According to ...rgentina, Oct. 3 The first reported,findings from...than,two-thirds of patients with moderate to sever...mab (CNTO 1275) achieved at least a 75 percent,red...
Other Medicine Technology:Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 2Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 3Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 4Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 5Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis 6(Date:11/29/2009)...get blamed for something leads to more self-defens...DAY, Nov. 29 (HealthDay News) -- The blame game is...the target is innocent. , Researchers found tha... problem, even if it,s an unfair accusation, they,...oo. , "When we see others protecting their ego...
(Date:11/28/2009)...GO, Nov. 28 Welcome to syngo...r the clinical routine from Siemens Healthcare. ...ons System (PACS) from Siemens where 2D, 3D, and... .plaza is poised to change the way multimodality ...nnovation at the 95th Scientific Assembly and An...
(Date:11/27/2009)...D, Mass., Nov. 27 GSI Gr...pplier of precision technology products and semico...eting of the Company,s shareholders has been sched...ation of the meeting will be announced in due cour... a requisition notice from Stephen Bershad, a hold...
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)...ing unprecedented medical, economic burdens, study... News) -- The number of people with diabetes in th...t 25 years, a new study predicts. , That would ...le with the disease, up from 23.7 million today. ,... with diabetes will triple, the study also warns, ...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3... very optimistic about Warfarin, an anti-clotting ...in patients suffering an abnormal heart rhythm, th...scores over the present treatment of Plavix plus a...,' Oral anticoagulants such as warfarin remain the...
...Pentagon placed new restrictions on a doctors’ ro... against any policy //that gives medical professi...ters’ to use harsher tactics than they would in t...ghts groups and medical ethicists. They charge tha...
...twins Amal and Amrutha, who became orphaned after ...ll be formally adopted by the Kerala Government at...being organised by Cheruvathur Grama Panchayat to ...a recent Cabinet meeting mooted the idea of adopti...
... popular excuse "not tonight, I have a headache," ...oid sexual activity and says that sexual desire an...mical. //
In fact, migraine sufferers report...d colleagues.
'Migraine patients in general m...
...as long been associated with mesothelioma and lung...gnancies as well //.
The Indian Institute of...addition IOM also concluded that there was ‘sugges...fficient evidence to relate asbestos to esophageal...
...nd Healthcare products Regulatory Agency (MHRA) wa...ulty readings. The diabetic patients are cautioned...e found to giving readings which were far too high...s of insulin resulting in hypoglycaemic coma.
...
Other Medicine News:Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:Laryngeal Cancer Added to Asbestos’ Crime Lis 2...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: